Health

Clinical Trials Find Stents Improve Survival Rate for Stroke Patients

This Friday, Feb. 6, 2015 photo shows stroke survivor Don Sadoway, foreground, and Lee Schwamm, vice chairman of the Massachusetts General Hospital's neurology department, in Boston. When medicine failed to dissolve a clot in Sadoway's brain, his wife agreed to let doctors try a new type of stent, and it worked. (AP Photo/Rodrique Ngowi)
This Friday, Feb. 6, 2015 photo shows stroke survivor Don Sadoway, foreground, and Lee Schwamm, vice chairman of the Massachusetts General Hospital’s neurology department, in Boston. When medicine failed to dissolve a clot in Sadoway’s brain, his wife agreed to let doctors try a new type of stent, and it worked. (AP Photo/Rodrique Ngowi)

(The Star-Tribune) – Surgeons who operate on blood vessels in the brain are hailing new data that suggest many more patients would survive strokes if they were treated with removable stents in addition to drugs.

Medtronic Inc. is cheering the news, since it now owns the Solitaire, a brain blood clot-removal device that commands a large market share for thrombectomy gadgets. The device came with Covidien, acquired by Medtronic last month, and is part of a Covidien neurovascular division expected to generate $451 million in sales this year.

Doctors, however, said the findings of lower mortality and better recovery are applicable to several companies’ devices, not just Covidien’s. That’s partly why they say the findings — first reported in December and confirmed in three publications in the New England Journal of Medicine this week — will ultimately lead to changes in national treatment guidelines for some types of stroke.

“Within the stroke community, this was one of the bigger events that has occurred in the last 20 years,” said Dr. Andrew Grande, a University of Minnesota neurosurgeon and an investigator on one of three studies published this week at the International Stroke Conference in Nashville.

READ MORE

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker